Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
Celio L, Cortinovis D, Cogoni AA, Cavanna L, Martelli O, Carnio S, Collovà E, Bertolini F, Petrelli F, Cassano A, Chiari R, Zanelli F, Pisconti S, Vittimberga I, Letizia A, Misino A, Gernone A, Bonizzoni E, Pilotto S, De Placido S, Bria E. Celio L, et al. Sci Rep. 2023 Jan 23;13(1):1257. doi: 10.1038/s41598-023-28464-9. Sci Rep. 2023. PMID: 36690734 Free PMC article. Clinical Trial.
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Milella M, Cavanna L, Di Marco MC, Spada M, Cordio S, Aprile G, Cardellino GG, Maiello E, Bernardini I, Ghidini M, Bozzarelli S, Macchini M, Orsi G, De Simone I, Rulli E, Porcu L, Torri V, Pinto C; GARIBALDI Study Group. Reni M, et al. ESMO Open. 2023 Feb;8(1):100777. doi: 10.1016/j.esmoop.2022.100777. Epub 2023 Feb 1. ESMO Open. 2023. PMID: 36731325 Free PMC article.
Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.
Bajetta E, Zilembo N, Di Bartolomeo M, Di Leo A, Pilotti S, Bochicchio AM, Castellani R, Buzzoni R, Celio L, Dogliotti L, et al. Bajetta E, et al. Among authors: celio l. Cancer. 1993 Nov 15;72(10):3099-105. doi: 10.1002/1097-0142(19931115)72:10<3099::aid-cncr2820721035>3.0.co;2-4. Cancer. 1993. PMID: 7693327 Clinical Trial.
Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology.
Buzzoni R, Biganzoli L, Bajetta E, Celio L, Fornasiero A, Mariani L, Zilembo N, Di Bartolomeo M, Di Leo A, Arcangeli G, et al. Buzzoni R, et al. Among authors: celio l. Br J Cancer. 1995 May;71(5):1111-4. doi: 10.1038/bjc.1995.215. Br J Cancer. 1995. PMID: 7734310 Free PMC article. Clinical Trial.
Formestane as treatment of advanced breast cancer in elderly women.
Zilembo N, Buzzoni R, Celio L, Noberasco C, Ferrari L, Laffranchi A, Vicario G, Dolci S, Bajetta E. Zilembo N, et al. Among authors: celio l. Tumori. 1994 Dec 31;80(6):433-7. doi: 10.1177/030089169408000605. Tumori. 1994. PMID: 7900232 Clinical Trial.
100 results